Leonardi CL - Search Results

1

A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis.

Leonardi CL, Toth D, Cather JC, Langley RG, Werther W, Compton P, Kwon P, Wetherill G, Curtin F, Menter A. Leonardi CL, et al. Dermatology. 2006;213(3):204-14. doi: 10.1159/000095037. Dermatology. 2006. PMID: 17033169

2

Efalizumab: an overview.

Leonardi CL. Leonardi CL. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S98-104. doi: 10.1016/s0190-9622(03)01141-1. J Am Acad Dermatol. 2003. PMID: 12894132 Review.

3

Efalizumab in the treatment of psoriasis.

Leonardi CL. Leonardi CL. Dermatol Ther. 2004;17(5):393-400. doi: 10.1111/j.1396-0296.2004.04042.x. Dermatol Ther. 2004. PMID: 15379774 Review.

4

Current concepts and review of efalizumab in the treatment of psoriasis.

Leonardi CL. Leonardi CL. Dermatol Clin. 2004 Oct;22(4):427-35, ix. doi: 10.1016/j.det.2004.03.015. Dermatol Clin. 2004. PMID: 15450338 Review.

5

Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.

Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL; EFALIZUMAB STUDY GROUP. Gottlieb AB, et al. Among authors: leonardi cl. J Drugs Dermatol. 2004 Nov-Dec;3(6):614-24. J Drugs Dermatol. 2004. PMID: 15624744 Clinical Trial.

6

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB; Efalizumab Study Group. Leonardi CL, et al. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):425-33. doi: 10.1016/j.jaad.2004.09.029. J Am Acad Dermatol. 2005. PMID: 15761420 Clinical Trial.

7

Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.

Gottlieb AB, Hamilton T, Caro I, Kwon P, Compton PG, Leonardi CL; Efalizumab Study Group. Gottlieb AB, et al. Among authors: leonardi cl. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S154-63. doi: 10.1016/j.jaad.2005.12.018. J Am Acad Dermatol. 2006. PMID: 16488337 Clinical Trial.

8

Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.

Papp KA, Miller B, Gordon KB, Caro I, Kwon P, Compton PG, Leonardi CL; Efalizumab Study Group. Papp KA, et al. Among authors: leonardi cl. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S164-70. doi: 10.1016/j.jaad.2005.10.032. J Am Acad Dermatol. 2006. PMID: 16488338 Clinical Trial.

9

Long-term management of plaque psoriasis with continuous efalizumab therapy.

Menter A, Leonardi CL, Sterry W, Bos JD, Papp KA. Menter A, et al. Among authors: leonardi cl. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S182-8. doi: 10.1016/j.jaad.2005.10.028. J Am Acad Dermatol. 2006. PMID: 16488340 Review. No abstract available.

10

Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I.

Pariser DM, Gordon KB, Papp KA, Leonardi CL, Kwon P, Compton PG, Rundle AC, Walicke PA, Lebwohl M. Pariser DM, et al. Among authors: leonardi cl. J Cutan Med Surg. 2005 Dec;9(6):303-12. doi: 10.1007/s10227-005-0116-1. J Cutan Med Surg. 2005. PMID: 16699904 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters